Gastroenterology, Hepatology & Digestive Disorders
Open Access
ISSN: 2639-9334
Research Article
View / Download PDF
Severe Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response
Authors: Bryce Yohannan, Maham Hayat, Taseen A. Syed, Muhammad Hashim Hayat, Diane Hughes, Javid Fazili.
Abstract
Citation:
Bryce Yohannan, Maham Hayat, Taseen A. Syed, et al. Severe Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response. Gastroint Hepatol Dig Dis. 2020; 3(1).
DOI:
10.33425/2639-9334.1039
Editor-in-Chief
Elisa Gravito Soares MF
Department of Gastroenterology | Coimbra University Hospital
View full editorial board →
Journal Metrics
Impact Factor
2.65*
Acceptance Rate
75%
Time to first decision
6 -10 Days
Submission to acceptance
12-15 Days